Project CBD

MARCH 21, 2023

She was upset with herself for being so careless and concerned that the condition would persist. For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. And it’s not just ringing. A review of the current literature.” And its conclusion?

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Project CBD

JUNE 20, 2023

Pain, anxiety, and sleep are major drivers of medical cannabis use. One gastrointestinal condition long associated with self-medication through cannabis is inflammatory bowel disease (IBD). But gastrointestinal symptoms, such as nausea and upset stomach, aren’t far behind. A flurry of recent research bears this out.

Cannabinoids 215

Cannabinoids Patients Treatment Conditions 215

MedicalJane

JUNE 12, 2020

All of the participants self-reported that they or their dependent patient had a diagnosed health condition at the time of the baseline assessment. A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

The Cannigma

SEPTEMBER 4, 2024

But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world data collected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms. And she got what she was looking for!

Data 98

Data CBD Collective Cannabinoids 98

Project CBD

FEBRUARY 27, 2023

Recently published papers — a series of reviews, two human studies, and an animal study — only bolster the case that cannabis can help those suffering from this confounding condition. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.”

THC 144

THC CBD Clinical Trials Sleep 144

Project CBD

MAY 3, 2023

And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. CannMed: For what conditions do you think CBG has the most promise? It was highly rated for anxiety, pain, depression, and sleep problems.

Cannabinoids 216

Cannabinoids Sleep Clinical Trials CBD 216

FloridaMarijuana.net

SEPTEMBER 24, 2018

Myrcene has potent anti-inflammatory, analgesic, and anxiolytic properties, and has benefit in muscle relaxation, and prominent sedation/hypnotic, helpful in sleep. Patients should speak with their certified medical marijuana physician to determine which strains and methods of consumption are most appropriate for their medical conditions.

Terpenes 162

Terpenes Oil Strains Research and Development 162

LifeCannMD

JANUARY 2, 2024

Medical Marijuana use has shown potential benefits in managing symptoms and improving the quality of life for individuals with various health conditions. This is the reason every Medical Marijuana state lists HIV/AIDS as one of their qualifying medical conditions.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

The Joint Blog

DECEMBER 18, 2019

Legal access to marijuana is associated with a decline in the sales of over-the-counter (OTC) sleep aid medications, according to a new study published in the journal Complementary Therapies in Medicine. – The negative association between cannabis access and sleep aid sales suggests a consumer preference for cannabis. .

Sleep 49

Sleep Legalization Marijuana Recreational 49

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 81

CBD Data Sleep Clinical Trials 81

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 111

Consumption Patients Research and Development Data 111

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. Human reports to date on the subject are largely anecdotal.

Data 114

Data Chronic Pain Sleep Patients 114

United Patients Group

MAY 17, 2023

Introduction Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects communication, social interactions and behaviors. Autism spectrum disorder (ASD) Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects communication, social interactions and behaviors.

Sleep 105

Sleep Cannabinoids Patients CBD 105

The Cannigma

FEBRUARY 25, 2021

In other words, BCP may aid in treating or preventing a multitude of conditions like infections, spasms, pain, and other neurologic conditions. What conditions and symptoms could benefit from b-caryophyllene. Pain is one of the primary conditions BCP is thought to benefit. Shutterstock). Andriy Popov/123rf).

Terpenes 131

Terpenes Oil Cannabinoids Conditions 131

The Cannigma

MARCH 2, 2021

The research team compiled the study by extracting archival data from Reddit’s open source application programming interface between 2008-2018. Veterans collectively discussed how the use of medical marijuana reduced PTSD symptoms, feelings of anxiety, and helped them sleep better. Pain management was mentioned by 7.8%

Research and Development 145

Research and Development Treatment Chronic Pain Sleep 145

Veriheal

APRIL 23, 2024

By engaging individuals across various age groups and demographics, we gather insights into usage patterns, medical conditions, past substance experiences, and more. We have also used some information provided by New Frontier Data in 2022, which referenced various studies and findings on this age demographic’s substance use.

Chronic Pain 111

Chronic Pain Data Edibles Sleep 111

The Cannigma

MARCH 25, 2021

My partner, who was diagnosed with Crohn’s Disease at the age of 19, was able to improve his quality of life with cannabis by managing his nausea, poor quality sleep, gut motility, appetite, pain, and anxiety with a single substance. The more I read about it, the more I became fascinated with the chemistry and potential of cannabis.

Patients 145

Patients Clinical Trials Medicine Events 145

Veriheal

AUGUST 15, 2022

People who suffer from fatigue may struggle with physical exertion, weight fluctuation, depression, emotional imbalance, and sleeping disturbances. The condition may also occur as a result of poor lifestyle habits, chronic disease, and depression. The Releaf App’s Role in the Fatigue Study.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). These patients also reported improved sleep and general quality of life.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

Veriheal

NOVEMBER 21, 2023

The buddie can be paired with a mobile app that tracks consumption, correlating it with health data from devices like WHOOP, Apple Watch, or Fitbit. buddie records various consumption methods and offers insights into the relationship between cannabis use and factors like exercise, sleep, and mood.

Research and Development 110

Research and Development Consumption Education Data 110

CannaMD

NOVEMBER 4, 2020

Developed with world-class neurologists, the Migraine Buddy app allows its 2 million-strong user community to record key information about their migraine attacks, including data before and during each attack, and share this information with their treating physician. Sleep improvement was also noted in 38.3% Similar findings of a 42.1%

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). Additionally, artisanal CBD users appear to fall below the clinical threshold for anxiety and enjoy a more consistent sleep pattern.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

The Cannigma

FEBRUARY 1, 2021

Still, the data also suggests that using cannabidiol (CBD) can reverse or prevent these issues — and that both CBD and THC may have big potential benefits for those suffering from Alzheimer’s disease. To do this, it regulates a number of bodily functions such as sleep, hunger, energy, temperature, pain, and immune function.

Terpenes 145

Terpenes THC Cannabinoids CBD 145

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. Spanagel R, Bilbao A.

CBD 144

CBD Seed-To-Sale Food Access 144

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Cannabis Law Report

AUGUST 9, 2021

The study will utilize Radicle Science’s data analytics platform and a virtual, direct-to-consumer model to deliver objective health outcome data across diverse populations and conditions. This randomized controlled trial will collect data on 13 U.S.

Hemp 105

Hemp CBD Legalization Edibles 105

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5. Easy access.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Healer

JANUARY 17, 2022

Trouble sleeping. People who want a hemp product to promote relaxation and sleep. People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. Attention deficit and hyperactivity. Inflammation. Who Should Try CBG vs CBD?

Cannabinoids 98

Cannabinoids CBD THC Research and Development 98

Veriheal

MAY 18, 2023

Chronic pain —a condition that affects 50.2 Once they felt satisfied with their takeaways, they put together specific guidelines featuring data from 70 studies, 51 of which were original studies and 19 of which were systematic reviews. million people in the U.S.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. of prescriptions were for sleep disorders. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. The Guardian writes.

Medicine 52

Medicine Clinical Trials Data Sleep 52

The Cannigma

AUGUST 24, 2021

The app also tracks the user’s preferred products, doesgae levels, how hungry they are afterwards, how much sleep they got afterwards, methods of consumption, and much more. As co-founder Otha Smith said, “through data, we aim to empower not only cannabis consumers, but the entire industry.”.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

The Joint Blog

DECEMBER 20, 2020

According to the study, respondents were most likely to report marijuana use for pain relief, improved sleep and to deal with nausea. “Respondents reported a median score of 90 on a zero to 100-point scale in response to the question, “How does cannabis affect your conditions or symptoms overall?”

Sleep 49

Sleep Data Pharmaceutical Marijuana 49

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Under what conditions can the deal be terminated? Access Psychiatry deal headline, upfront, milestone and royalty data. American Sleep Apnea Association. Trends in Psychiatry dealmaking in the biopharma industry since 2014. Analysis of Psychiatry deal structure.

Access 40

Access Data Pharmaceutical Research and Development 40

Veriheal

OCTOBER 3, 2022

The team that conducted the study looked at stock return and prescription drug sales data for 556 pharmaceutical companies. However, unlike a conventional new generic drug, cannabis use is not restricted to a single or limited set of conditions. The Impact of Cannabis Legalization on Big Pharma.

Pharmaceutical 105

Pharmaceutical Patients Research and Development Legalization 105

Cannabis Law Report

MAY 3, 2022

Sleep disorders are a common problem around the world. The most frequent issues affecting sleep are insomnia, sleep apnea, and restless legs. Having trouble getting a good night’s sleep can result in daytime sleepiness, affecting your job and daily life. It’s more common in women, but men also suffer from this condition.

Sleep 52

Sleep Research and Development Conditions Vaping 52